21st Mar 2022 7:00 am |
RNS |
Holding(s) in Company |
18th Mar 2022 5:13 pm |
RNS |
Holding(s) in Company |
16th Mar 2022 3:33 pm |
RNS |
Holding(s) in Company |
15th Mar 2022 4:34 pm |
RNS |
Holding(s) in Company |
11th Mar 2022 9:30 am |
RNS |
Close of Subscription and Fundraise Update |
4th Mar 2022 4:13 pm |
RNS |
Result of Fundraise |
4th Mar 2022 12:20 pm |
RNS |
Close of Accelerated Bookbuild |
4th Mar 2022 7:10 am |
RNS |
Proposed Fundraise |
15th Feb 2022 7:00 am |
RNS |
Successful completion of analytical validation |
26th Jan 2022 4:28 pm |
RNS |
Net Asset Value(s) |
14th Jan 2022 7:00 am |
RNS |
Investor Presentation |
12th Jan 2022 2:00 pm |
RNS |
Progress and strategy update |
6th Jan 2022 7:00 am |
RNS |
Clarava™ and Tuteva™ complete testing requirements |
5th Jan 2022 7:00 am |
RNS |
Collaboration with Illumina |
4th Jan 2022 7:00 am |
RNS |
Grant of two CPT Codes by AMA |
17th Dec 2021 1:19 pm |
RNS |
Holding(s) in Company |
8th Nov 2021 7:00 am |
RNS |
Launch of Barbara T. Murphy Endowed Lectureship |
1st Nov 2021 7:00 am |
RNS |
Launch of Career Development Research Grant |
13th Sep 2021 7:01 am |
RNS |
Lorenzo Gallon, MD, Appointed as Chair of S.A.B |
13th Sep 2021 7:00 am |
RNS |
Half-year Report |
31st Aug 2021 7:00 am |
RNS |
Patient enrolment completed |
19th Aug 2021 7:00 am |
RNS |
Appointment of Non-executive Director |
27th Jul 2021 7:00 am |
RNS |
Acceptance to CLIA Program |
20th Jul 2021 7:00 am |
RNS |
First European Clinical Trial Site Initiated |
1st Jul 2021 4:56 pm |
RNS |
Directorate Change |
24th Jun 2021 7:00 am |
RNS |
Non-executive Director receives award |
26th May 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
26th May 2021 4:35 pm |
RNS |
Price Monitoring Extension |
19th May 2021 3:14 pm |
RNS |
Result of AGM |
5th May 2021 7:00 am |
RNS |
Notice of Change of AGM Venue |
29th Apr 2021 7:00 am |
RNS |
Lease signed for laboratory |
14th Apr 2021 7:01 am |
RNS |
MTA secured to assess CTOT-19 samples |
14th Apr 2021 7:00 am |
RNS |
Final Results |
13th Apr 2021 2:06 pm |
RNS |
Second Price Monitoring Extn |
13th Apr 2021 2:01 pm |
RNS |
Price Monitoring Extension |
13th Apr 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
13th Apr 2021 11:00 am |
RNS |
Price Monitoring Extension |
17th Mar 2021 7:00 am |
RNS |
Notice of Results |
2nd Mar 2021 7:00 am |
RNS |
First clinical trial sites initiated in US |
9th Feb 2021 7:00 am |
RNS |
Capital Markets Day for Kidney Health |